Implementation Evaluation of the DAC Flagship Study

Currently more than 55 million people globally are living with Alzheimer’s which is estimated to impose a 1.3 trillion dollar annual boat. By 2050, it’s expected that the number of cases will rise to 152 million at an annual cost of 2.8 Trillion annually. The Davos Alzheimer’s Collaborative (DAC) was initiated in 2020 by the World Economic Forum to accelerate the discovery, testing, and delivery of precision interventions for Alzheimer’s disease. A key part of this initiative is a Health Systems Preparedness workstream which aims to expand access to screening and diagnosis by offering novel tools in non-specialist settings globally. Access to screening and diagnosis is currently confined to specialist settings and thus inaccessible to the majority of people. Research has shown that 3 out of 4 people with dementia are never diagnosed or treated. The present study aims to evaluate the implementation of digital cognitive screening and a blood-based biomarker test across 7 different healthcare settings globally. This study will use implementation science to identify barriers and facilitators to
implementation and capture resources and lessons learned in a durable digital toolkit.

Faculty Supervisor:

Sara Ahmed

Student:

Partner:

Bridgeable Inc.

Discipline:

Sociology

Sector:

Management of companies and enterprises

University:

McGill University

Program: